Trial Profile
Outcome of intraperitoneal Cisplatinum and Taxol in patients with ovarian cancer
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 30 Jun 2008
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Paclitaxel (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 30 Jun 2008 New trial record.